Thomas R Radomski1,2, Xinhua Zhao2, Carolyn T Thorpe2,3, Joshua M Thorpe2,3, Chester B Good1,2,3,4, Maria K Mor2,5, Michael J Fine1,2, Walid F Gellad6,7. 1. Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 2. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, University Drive, 151C, Pittsburgh, PA, 15240, USA. 3. Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA. 4. Pharmacy Benefits Management Services, U.S. Department of Veterans Affairs, Hines, IL, USA. 5. Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. 6. Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. walid.gellad@va.gov. 7. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, University Drive, 151C, Pittsburgh, PA, 15240, USA. walid.gellad@va.gov.
Abstract
BACKGROUND: Many Veterans treated within the VA Healthcare System (VA) are also enrolled in fee-for-service (FFS) Medicare and receive treatment outside the VA. Prior research has not accounted for the multiple ways that Veterans receive services across healthcare systems. OBJECTIVE: We aimed to establish a typology of VA and Medicare utilization among dually enrolled Veterans with type 2 diabetes. DESIGN: This was a retrospective cohort. PARTICIPANTS: 316,775 community-dwelling Veterans age ≥ 65 years with type 2 diabetes who were dually enrolled in the VA and FFS Medicare in 2008-2009. METHODS: Using latent class analysis, we identified classes of Veterans based upon their probability of using VA and Medicare diabetes care services, including patient visits, laboratory tests, glucose test strips, and medications. We compared the amount of healthcare use between classes and identified factors associated with class membership using multinomial regression. KEY RESULTS: We identified four distinct latent classes: class 1 (53.9%) had high probabilities of VA use and low probabilities of Medicare use; classes 2 (17.2%), 3 (21.8%), and 4 (7.0%) had high probabilities of VA and Medicare use, but differed in their Medicare services used. For example, Veterans in class 3 received test strips exclusively through Medicare, while Veterans in class 4 were reliant on Medicare for medications. Living ≥ 40 miles from a VA predicted membership in classes 3 (OR 1.1, CI 1.06-1.15) and 4 (OR 1.11, CI 1.04-1.18), while Medicaid eligibility predicted membership in class 4 (OR 4.30, CI 4.10-4.51). CONCLUSIONS: Veterans with diabetes can be grouped into four distinct classes of dual health system use, representing a novel way to characterize how patients use multiple services across healthcare systems. This classification has applications for identifying patients facing differential risk from care fragmentation.
BACKGROUND: Many Veterans treated within the VA Healthcare System (VA) are also enrolled in fee-for-service (FFS) Medicare and receive treatment outside the VA. Prior research has not accounted for the multiple ways that Veterans receive services across healthcare systems. OBJECTIVE: We aimed to establish a typology of VA and Medicare utilization among dually enrolled Veterans with type 2 diabetes. DESIGN: This was a retrospective cohort. PARTICIPANTS: 316,775 community-dwelling Veterans age ≥ 65 years with type 2 diabetes who were dually enrolled in the VA and FFS Medicare in 2008-2009. METHODS: Using latent class analysis, we identified classes of Veterans based upon their probability of using VA and Medicare diabetes care services, including patient visits, laboratory tests, glucose test strips, and medications. We compared the amount of healthcare use between classes and identified factors associated with class membership using multinomial regression. KEY RESULTS: We identified four distinct latent classes: class 1 (53.9%) had high probabilities of VA use and low probabilities of Medicare use; classes 2 (17.2%), 3 (21.8%), and 4 (7.0%) had high probabilities of VA and Medicare use, but differed in their Medicare services used. For example, Veterans in class 3 received test strips exclusively through Medicare, while Veterans in class 4 were reliant on Medicare for medications. Living ≥ 40 miles from a VA predicted membership in classes 3 (OR 1.1, CI 1.06-1.15) and 4 (OR 1.11, CI 1.04-1.18), while Medicaid eligibility predicted membership in class 4 (OR 4.30, CI 4.10-4.51). CONCLUSIONS: Veterans with diabetes can be grouped into four distinct classes of dual health system use, representing a novel way to characterize how patients use multiple services across healthcare systems. This classification has applications for identifying patients facing differential risk from care fragmentation.
Entities:
Keywords:
Medicare; Veterans; diabetes; health services research; utilization
Authors: Joseph Menzin; Jonathan R Korn; Joseph Cohen; Francis Lobo; Bin Zhang; Mark Friedman; Peter J Neumann Journal: J Manag Care Pharm Date: 2010-05
Authors: Huanguang Jia; Yu Zheng; Dean M Reker; Diane C Cowper; Samuel S Wu; W Bruce Vogel; Gail C Young; Pamela W Duncan Journal: Stroke Date: 2006-12-28 Impact factor: 7.914
Authors: Denise M Hynes; Kristin Koelling; Kevin Stroupe; Noreen Arnold; Katherine Mallin; Min-Woong Sohn; Frances M Weaver; Larry Manheim; Linda Kok Journal: Med Care Date: 2007-03 Impact factor: 2.983
Authors: Thomas R Radomski; Xinhua Zhao; Carolyn T Thorpe; Joshua M Thorpe; Jennifer G Naples; Maria K Mor; Chester B Good; Michael J Fine; Walid F Gellad Journal: J Gen Intern Med Date: 2017-05-01 Impact factor: 5.128
Authors: Thomas R Radomski; Xinhua Zhao; Joseph T Hanlon; Joshua M Thorpe; Carolyn T Thorpe; Jennifer G Naples; Florentina E Sileanu; John P Cashy; Jennifer A Hale; Maria K Mor; Leslie R M Hausmann; Julie M Donohue; Katie J Suda; Kevin T Stroupe; Chester B Good; Michael J Fine; Walid F Gellad Journal: Healthc (Amst) Date: 2019-04-26
Authors: Thomas R Radomski; Felicia R Bixler; Susan L Zickmund; KatieLynn M Roman; Carolyn T Thorpe; Jennifer A Hale; Florentina E Sileanu; Leslie R M Hausmann; Joshua M Thorpe; Katie J Suda; Kevin T Stroupe; Adam J Gordon; Chester B Good; Michael J Fine; Walid F Gellad Journal: J Gen Intern Med Date: 2018-03-08 Impact factor: 5.128
Authors: Ron Carico; Xinhua Zhao; Carolyn T Thorpe; Joshua M Thorpe; Florentina E Sileanu; John P Cashy; Jennifer A Hale; Maria K Mor; Thomas R Radomski; Leslie R M Hausmann; Julie M Donohue; Katie J Suda; Kevin Stroupe; Joseph T Hanlon; Chester B Good; Michael J Fine; Walid F Gellad Journal: Ann Intern Med Date: 2018-10-09 Impact factor: 25.391
Authors: Rebecca Kartje; Brian E Dixon; Ashley L Schwartzkopf; Vivian Guerrero; Kimberly M Judon; Joanne C Yi; Kenneth Boockvar Journal: J Am Board Fam Med Date: 2021 Mar-Apr Impact factor: 2.657
Authors: Winn Cashion; Walid F Gellad; Florentina E Sileanu; Maria K Mor; Michael J Fine; Jennifer Hale; Daniel E Hall; Shari Rogal; Galen Switzer; Mohan Ramkumar; Virginia Wang; Douglas A Bronson; Mark Wilson; William Gunnar; Steven D Weisbord Journal: Clin J Am Soc Nephrol Date: 2021-02-18 Impact factor: 8.237
Authors: Katherine M Prenovost; Stephan D Fihn; Matthew L Maciejewski; Karin Nelson; Sandeep Vijan; Ann-Marie Rosland Journal: PLoS One Date: 2018-11-26 Impact factor: 3.240
Authors: Lianlian Lei; Julie Strominger; Ilse R Wiechers; H Myra Kim; Frederic C Blow; Amy S B Bohnert; Lillian Min; Sarah L Krein; Donovan T Maust Journal: J Gen Intern Med Date: 2021-05-28 Impact factor: 6.473